Gadicke Ansbert's Form 4 filing
Repare Therapeutics Inc. (RPTX) · filed Jul 13, 2021
- Accession no.
- 0001209191-21-046491
- Filed
- Jul 13, 2021
- Trade date
- Jul 9-12, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.08M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gadicke AnsbertCIK 0001134655 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2021 | Common Shares | SSaleDisposed | −4,067 | $33.06 | −$134,455.02 | 3,940,497 | Indirect | |
| Jul 12, 2021 | Common Shares | SSaleDisposed | −57,301 | $33.58 | −$1,924,167.58 | 3,883,196 | Indirect | |
| Jul 12, 2021 | Common Shares | SSaleDisposed | −711 | $34.10 | −$24,245.1 | 3,882,485 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.